Monash IVF Group (ASX:MVF shareholders incur further losses as stock declines 30% this week, taking one-year losses to 58%

Investing in stocks comes with the risk that the share price will fall. And unfortunately for Monash IVF Group Limited (ASX:MVF) shareholders, the stock is a lot lower today than it was a year ago. The share price is down a hefty 60% in that time. Even if you look out three years, the returns are still disappointing, with the share price down45% in that time. Furthermore, it's down 52% in about a quarter. That's not much fun for holders.

If the past week is anything to go by, investor sentiment for Monash IVF Group isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During the last year Monash IVF Group saw its earnings per share drop below zero. Buyers no doubt think it's a temporary situation, but those with a nose for quality have low tolerance for losses. However, there may be an opportunity for investors if the company can recover.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

Dive deeper into Monash IVF Group's key metrics by checking this interactive graph of Monash IVF Group's earnings, revenue and cash flow.

A Different Perspective

Investors in Monash IVF Group had a tough year, with a total loss of 58% (including dividends), against a market gain of about 13%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 2%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that Monash IVF Group is showing 2 warning signs in our investment analysis , and 1 of those can't be ignored...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.